These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29181163)

  • 21. Clinical approach to the prostate: an update.
    Kutikov A; Guzzo TJ; Malkowicz SB
    Radiol Clin North Am; 2006 Sep; 44(5):649-63, vii. PubMed ID: 17030218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress in benign prostatic hyperplasia: a systematic review.
    Minciullo PL; Inferrera A; Navarra M; Calapai G; Magno C; Gangemi S
    Urol Int; 2015; 94(3):249-54. PubMed ID: 25503259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis.
    Goswami K; Nandeesha H; Koner BC; Nandakumar DN
    Prostate Cancer Prostatic Dis; 2007; 10(4):356-9. PubMed ID: 17404581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.
    Colinot DL; Garbuz T; Bosland MC; Wang L; Rice SE; Sullivan WJ; Arrizabalaga G; Jerde TJ
    Prostate; 2017 Jul; 77(10):1066-1075. PubMed ID: 28497488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic Calculi: Do They Matter?
    Cao JJ; Huang W; Wu HS; Cao M; Zhang Y; Jin XD
    Sex Med Rev; 2018 Jul; 6(3):482-491. PubMed ID: 29157875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benign prostate hyperplasia with chronic prostatitis: an update].
    Ma Y; Zhang WL
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis.
    Elkahwaji JE; Zhong W; Hopkins WJ; Bushman W
    Prostate; 2007 Jan; 67(1):14-21. PubMed ID: 17075821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
    Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
    BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological treatment for common prostatic conditions in dogs - benign prostatic hyperplasia and prostatitis: an update.
    Niżański W; Levy X; Ochota M; Pasikowska J
    Reprod Domest Anim; 2014 Jun; 49 Suppl 2():8-15. PubMed ID: 24947855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma?
    Hoover P; Naz RK
    Int J Androl; 2012 Aug; 35(4):608-15. PubMed ID: 22321000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor-α expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification.
    Engelhardt PF; Seklehner S; Brustmann H; Riedl C; Lusuardi L
    Scand J Urol; 2015 Dec; 49(6):472-478. PubMed ID: 25959105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.
    Sikka SC
    Curr Med Chem; 2003 Dec; 10(24):2679-92. PubMed ID: 14529458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
    Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
    Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).
    Lokant MT; Naz RK
    Andrologia; 2015 Apr; 47(3):328-32. PubMed ID: 24620795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.
    Lorenzo G; Hughes TJR; Dominguez-Frojan P; Reali A; Gomez H
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1152-1161. PubMed ID: 30617074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress in benign prostate hyperplasia.
    Zabaiou N; Mabed D; Lobaccaro JM; Lahouel M
    Andrologia; 2016 Feb; 48(1):69-73. PubMed ID: 25959539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.